TALARIS THERAPEUTICS Trademark

Trademark Overview

On Friday, November 16, 2018, a trademark application was filed for TALARIS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TALARIS THERAPEUTICS trademark a serial number of 88197017. The federal status of this trademark filing is REGISTERED as of Tuesday, October 20, 2020. This trademark is owned by Regenerex, Inc.. The TALARIS THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Providing laboratory services to hospitals and transplant centers involving manipulation of allogeneic cells used for cell therapy treatment of organ transplant patients

Biological preparations in the nature of allogeneic cell therapies for use in treating organ transplant patients
talaris therapeutics

General Information

Serial Number88197017
Word MarkTALARIS THERAPEUTICS
Filing DateFriday, November 16, 2018
Status700 - REGISTERED
Status DateTuesday, October 20, 2020
Registration Number6180755
Registration DateTuesday, October 20, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2019

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesProviding laboratory services to hospitals and transplant centers involving manipulation of allogeneic cells used for cell therapy treatment of organ transplant patients
Goods and ServicesBiological preparations in the nature of allogeneic cell therapies for use in treating organ transplant patients

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 1, 1970
Primary Code005
First Use Anywhere DateWednesday, February 26, 2020
First Use In Commerce DateWednesday, February 26, 2020
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 8, 2019
Primary Code042
First Use Anywhere DateWednesday, February 26, 2020
First Use In Commerce DateWednesday, February 26, 2020

Trademark Owner History

Party NameTALARIS THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLOUISVILLE, KY 40202
Party NameTALARIS THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressLOUISVILLE, KY 40202
Party NameRegenerex, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLouisville, KY 40202
Party NameRegenerex, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLouisville, KY 40202

Trademark Events

Event DateEvent Description
Tuesday, November 20, 2018NEW APPLICATION ENTERED
Tuesday, December 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 20, 2019ASSIGNED TO EXAMINER
Thursday, February 28, 2019NON-FINAL ACTION WRITTEN
Thursday, February 28, 2019NON-FINAL ACTION E-MAILED
Thursday, February 28, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 27, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 2, 2019ASSIGNED TO LIE
Wednesday, September 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 27, 2019FINAL REFUSAL WRITTEN
Friday, September 27, 2019FINAL REFUSAL E-MAILED
Friday, September 27, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, October 8, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 8, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, October 8, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 8, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, October 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 9, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2019PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 6, 2020SOU TEAS EXTENSION RECEIVED
Monday, July 6, 2020SOU EXTENSION 1 FILED
Monday, July 6, 2020SOU EXTENSION 1 GRANTED
Tuesday, July 7, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 7, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 7, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 7, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 7, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 7, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 7, 2020TEAS STATEMENT OF USE RECEIVED
Friday, August 7, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, August 12, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 18, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 7, 2020SOU EXTENSION 2 FILED
Tuesday, August 18, 2020SOU EXTENSION 2 GRANTED
Friday, August 7, 2020USE AMENDMENT FILED
Tuesday, August 18, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 15, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 16, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 20, 2020REGISTERED-PRINCIPAL REGISTER
Monday, October 20, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

therapeutics talaris transplant organ patients cell allogeneic treatment preparations treating therapies nature